Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, and Gallwitz B
The GLP-1 Foundation Semaglutide (sold as Ozempic for type 2 diabetes and Wegovy for weight management) works primarily by mimicking glucagon-like peptide-1 (GLP-1)
(5) Dysmorphic features, developmental delay, or endocrinopathies (e.g., central hypothyroidism, GH or ACTH deficiency) [107] and (6) Normal or accelerated linear growth (suggesting genetic rather than hypothalamic etiology, especially in MC4R mutated-patients)
This includes an assessment of liver function, skin condition, lifestyle, and any pre-existing health issues
The lowest equivalents require longer prepaid terms